Immunology, Hepatology, Dermatology (IHD) has 10 pipeline projects in Phase 3 or registration and over 25 projects in Phase 1/2. Our IHD Unit has a pipeline with depth and breadth, and is known to be a talent powerhouse.
We are uniquely positioned to have a critical impact on bringing innovative medicines to patients across multiple disease areas.
Our team works in a curious, inspired and unbossed culture. We work together across all functions to maximize our performance and achievements. We are a team full of smart, passionate, and dedicated individuals that keeps the patient at the center of all we do. We are committed to helping each other develop and grow our careers throughout Novartis.
Just imagine how many patients YOU could impact as part of our team!
The MSL Manager will lead scientific engagement with the medical/scientific community by implementing and partnering on clinical and educational strategies. Develop, influence, align and collaborate with medical experts (MEs) to co-create value and change the practice of medicine. Inform medical strategies through robust insight-generation.
Your responsibilities will include:
*Leverage scientific expertise and market knowledge to develop and cultivate professional relationships with MEs, key stakeholders (KSHs), and other influencers in geo-graphical area as aligned with medical unit (MU) strategy *Verbalize complex data in a way that is impactful with a variety of stakeholders *Ensure appropriate identification, mapping, and planning of MEs and Key Accounts as aligned to MU Strategy and in collaboration with other Novartis colleagues *Respond to unsolicited requests for information from MEs by sharing appropriate da-ta in a timely, compliant, and ME-focused manner *Drive mutually high value ME interactions including identification of opportunities to involve MEs when a specific medical need is identified (e.g., publications, clinical trial participation) *In collaboration with clinical trial personnel, provide clinical research support and optimize trial execution specific to the geography for relevant therapeutic area. *Apply foundational impactful Scientific Engagement Model (iSEM) principles to ME interactions in alignment with MU strategy and product prioritization *Inform and shape medical strategy through application of a curious mindset to collect impactful insights, understanding the strategic impact of critical insights *Support product pre-launch, launch, and post-launch activities and communication plans per MU strategy and tactical plans *Discuss customer interest in Investigator Initiated Trials (IITs) in alignment with gap analysis.